In a point/counter point format, the utility of clinical metagenomics to impact patient outcomes are discussed. Two teams, each with an infectious disease physician and a Micro director from opposite side of this issue.
Point-counter Point: Clinical Metagenomics Is It Worth the Juice
Steve Miller, MD PhD, University of California San Francisco, San Francisco, CA, USA
Stephanie L. Mitchell, PhD, D(ABMM), University of Pittsburgh, Pittsburgh, PA, USA
William J. Muller, MD, PhD, Lurie Children's Hospital of Chicago; Northwestern University Feinberg School of
Medicine, Chicago, IL, USA
Debra Palazzi, MD, MEd, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA
Objectives:
- Discuss the advantages and clinical utility of metagenomics for use in patient care.
- Describe the downsides or harm that metagenomics can cause to patient care.
- Identify clinical situations in which metagenomics is or is not appropriate.
Recording Date: November 18, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.50 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
